SPONTANEOUS PLATELET ACTIVATION AND AGGREGATION DURING OBSTRUCTIVE SLEEP-APNEA AND ITS RESPONSE TO THERAPY WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE
G. Bokinsky et al., SPONTANEOUS PLATELET ACTIVATION AND AGGREGATION DURING OBSTRUCTIVE SLEEP-APNEA AND ITS RESPONSE TO THERAPY WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE, Chest, 108(3), 1995, pp. 625-630
Study objective: To determine whether alterations of platelet reactivi
ty occur during obstructive sleep apnea (OSA) and, if so, whether ther
apy with nasal-continuous positive airway pressure (N-CPAP) alters thi
s reactivity. Design: Patients with suspected moderate to severe OSA h
ad blood drawn for spontaneous platelet aggregation (sAGG) and activat
ion (sACT) measurements at hourly intervals during diagnostic polysomn
ography (PSG) and, in those with confirmed OSA, on a separate night du
ring which N-CPAP was applied. Setting: Tertiary care center sleep lab
oratory. Patients: Six patients with OSA had matched blood samples dra
wn on both diagnostic and N-CPAP treatment nights. Five patients witho
ut confirmed OSA served as controls. Interventions: N-CPAP was applied
to those patients with OSA and pressures adjusted with goals of elimi
nating apneas; IV-CPAP was then maintained through the night. Measurem
ents and results: sACT and sAGG were measured using flow cytometric de
termination of P-selectin expression using a monoclonal antibody. Plat
elet aggregation was assessed by measuring the proportion of platelets
larger than resting platelets by light scatter techniques. Mean value
s for sACT and sAGG were higher on the diagnostic night compared with
treatment night (p=0.001 and p=0.003, analysis of variance, respective
ly). The mean baseline supine sACT compared with completion supine sAC
T for both diagnostic and N-CPAP nights also revealed significant diff
erences (mean=16.6+/-3.5% vs 36.9+/-7.5%, p=0.04; and 11.9+/-3% vs 39.
5+/-9.1%, p=0.04). Platelet activation during sleep in five subjects w
ithout OSA resembles that found in patients with OSA during N-CPAP. Co
nclusions: Increased platelet sACT and sAGG occur during sleep in pati
ents with OSA. This effect is greatly reduced by N-CPAP.